Comoros vs Dominica: HIV/AIDS deaths averted by antiretroviral therapy
Comoros
7.94 deaths
in 2024
Dominica
6.73 deaths
in 2024
Comoros rank
154th
Dominica rank
155th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Comoros
- Dominica
How they compare
Comoros currently reports 7.94 deaths against 6.73 deaths in Dominica, a difference of 1.21 deaths.
That makes Comoros's figure about 1.2 times Dominica's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Dominica ahead.
Comoros ranks 154th and Dominica ranks 155th of 157 countries.
Across the 4 decades both report, Comoros averaged higher in 1 and Dominica in 2.
Head to head by decade
| Decade | Comoros | Dominica | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 0 deaths | 2.35 deaths | 2.35 deaths | Dominica |
| 2010s | 4.45 deaths | 4.86 deaths | 0.4113 deaths | Dominica |
| 2020s | 7.51 deaths | 6.02 deaths | 1.48 deaths | Comoros |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Comoros or Dominica?
- Comoros, at 7.94 deaths against 6.73 deaths in Dominica as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Comoros and Dominica?
- 1.21 deaths, with Comoros ahead.
- How many years of comparable data are there for Comoros and Dominica?
- 35 years are reported by both, from 1990 to 2024.
- How do Comoros and Dominica rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Comoros ranks 154th and Dominica ranks 155th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.